BIO 2013: It's the outcomes, stupid
This article was originally published in Scrip
Executive Summary
The fundamental problem with the pharmaceutical industry’s old business model could be astonishingly similar to the elusive challenge to balance healthcare quality and costs. Different times call for people to be working toward different goals. Biopharma and the healthcare system are working to the wrong goal.